-
Mashup Score: 4Excess Weight Gain With Integrase Inhibitors and Tenofovir Alafenamide: What Is the Mechanism and Does It Matter? - 3 year(s) ago
Abstract. Numerous studies have detected a greater likelihood of excess weight gain with specific antiretrovirals (ARVs), particularly tenofovir alafenamide and
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 4
Abstract. Among 880 healthcare workers with a positive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test, 264 (30.0%) infections were identified
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
OFID: Among health care workers with a positive SARS-CoV-2 test, cycle threshold values were highest among individuals receiving two vaccine doses, corresponding to lower viral shedding. 📄: https://t.co/reHcVukOtd #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @PAdamsonMD https://t.co/i5XT9in8mh
-
-
Mashup Score: 3COVID-19-associated Invasive Fungal Infection - 3 year(s) ago
Abstract. COVID-19 can become complicated by secondary invasive fungal infections (IFI), stemming primarily from severe lung damage and immunologic deficits ass
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
A new article in OFID reviews COVID-19-associated fungal infections and addresses gaps in knowledge relating to the epidemiology, diagnosis and management of these infections: https://t.co/JIkkW70zHI #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @jobadd @DrPappasID https://t.co/bPmFdKkjmb
-
-
Mashup Score: 13Multiple-Dose Dalbavancin Regimens as the Predominant Treatment of Deep-Seated or Endovascular Infections: A Scoping Review - 3 year(s) ago
Evidence for the use of multiple-dose dalbavancin regimens as the predominant therapy for deep-seated or endovascular infections is limited. Limitations of the
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
A new review in OFID found that evidence for the use of multiple-dose dalbavancin regimens as the predominant therapy for deep-seated or endovascular infections is limited: https://t.co/nFerDtDP4P #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @maggiecooper06 https://t.co/JnENAyXXt6
-
-
Mashup Score: 10Antifungal Susceptibility Testing: A Primer for Clinicians - 3 year(s) ago
Abstract. Clinicians treating patients with fungal infections may turn to susceptibility testing to obtain information regarding the activity of different antif
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
New in OFID: An overview for clinicians on antifungal susceptibility testing, including testing methods and their limitations, and how results may or may not be clinically useful. 📄:https://t.co/ZhPL5oQ57F #OpenForumInfectDis #IDSAJournals @PaulSaxMD @DrJLi https://t.co/wrIkBc5MPV
-
-
Mashup Score: 0
Abstract. The United States has well-documented rural-urban health disparities and it is imperative that these are not exacerbated by an inefficient roll-out of
Source: OUP AcademicCategories: General Medicine News, Latest HeadlinesTweet-
To ensure rural residents receive the vaccine, community officials should look to previous research on how to communicate vaccine information and implement programs. https://t.co/4KDNFwM6B8 @bethp_DI @IDSAInfo #IDSAJournals #VaccinesWork #WorldImmunizationWeek #OpenForumInfectDis https://t.co/HCjYrS3mT8
-
-
Mashup Score: 4
Early in COVID-19 pandemic, institutions developed treatment protocols based on limited evidence. In this analysis of those protocols, we found marked heterogen
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
New in OFID, a mixed-methods analysis of COVID-19 treatment protocols developed by North American health care facilities early in the pandemic. 📄: https://t.co/Mj4e7gfODk #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi @channermdcm @BranchWestyn https://t.co/sQUoX2csjc
-
-
Mashup Score: 1Inflammatory Markers During Early Treatment of Seroconverters in a Randomized Placebo-Controlled Trial of PrEP (ANRS-IPERGAY) - 4 year(s) ago
In seventeen HIV-seroconverters in a PrEP trial who were treated very early on, inflammation peaked at the time of HIV-infection and returned to pre-HIV-infecti
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
New in OFID: A small study of 17 HIV-#seroconverters in a PrEP trial suggests that starting antiretroviral therapy very early could help mitigate long-lasting #HIV-related inflammation. 📄: https://t.co/72wQ2pfpXY #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi https://t.co/qb4D6VroFN
-
-
Mashup Score: 0effect of antibiotic restriction programs on prevalence of antimicrobial resistance: a systematic review and meta-analysis - 4 year(s) ago
AbstractBackground. In hospital settings, restriction of selected classes of antibiotics is usually believed to contribute to containment of resistance developm
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
OFID: A new systematic review and meta-analysis assesses the effect of policies restricting the use of specific antibiotic classes on the prevalence of antimicrobial resistance. 📄: https://t.co/GL1tgtR4LG #IDSAJournals #OpenForumInfectDis @PaulSaxMD @DrJLi https://t.co/D1yYupXPhc
-
-
Mashup Score: 0Human Challenge Studies with Wild Type SARS-CoV-2 Violate Longstanding Codes of Human Subjects Research - 4 year(s) ago
Abstract. This manuscript explores the ethics of human inoculation experiments in young healthy adults with wild type SARS-CoV-2 as a tool to evaluate vaccine e
Source: OUP AcademicCategories: Infectious Disease, Latest HeadlinesTweet-
A new OFID perspective explores the ethics of human challenge studies with #SARSCoV2 as a tool to evaluate vaccine efficacy in the context of longstanding codes governing human subjects research. 📄: https://t.co/S0Xrty7WG2 #IDSAJournals #OpenForumInfectDis @PaulSaxMD https://t.co/isOQzgNJOU
-
A new article in OFID reviews the evidence and clinical implications for possible mechanisms underlying excess weight gain associated with specific antiretrovirals for #HIV treatment: https://t.co/lUlHyCfA6a #OpenForumInfectDis #IDSAJournals @PaulSaxMD @DrJLi https://t.co/RA3M8lQCnd